IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v46y2023i6d10.1007_s40264-023-01285-5.html
   My bibliography  Save this article

Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance

Author

Listed:
  • Priya Bahri

    (Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
    European Medicines Agency (EMA) (Coordinator of the ISoP CommSIG in Her Personal Capacity))

  • Geoffrey Bowring

    (Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
    Uppsala Monitoring Centre (UMC))

  • Brian D. Edwards

    (Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
    Husoteria Ltd)

  • Christopher Anton

    (Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
    City Hospital)

  • Jeffrey K. Aronson

    (Nuffield Department of Primary Care Health Sciences)

  • Angela Caro-Rojas

    (Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
    Pontificia Universidad Javeriana)

  • Bruce P. J. Hugman
  • Peter G. Mol

    (Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
    University of Groningen)

  • Gianluca Trifirò

    (University of Verona)

  • Katarina Ilic

    (Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
    Takeda)

  • Riadh Daghfous

    (Tunisian National Centre of Pharmacovigilance)

  • Irene Fermont

    (Israel Society for Medication and Vaccine Safety (ERANIM))

  • Giovanni Furlan

    (Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
    Pfizer s.r.l., Safety Surveillance and Risk Management)

  • Wolfgang Gaissmaier

    (University of Konstanz)

  • Mohammad Ishaq Geer

    (University of Kashmir)

  • Kenneth Y. Hartigan-Go

    (Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
    Ateneo De Manila University)

  • François Houÿez

    (European Organisation for Rare Diseases (EURORDIS))

  • Hansjörg Neth

    (University of Konstanz)

  • Gediminas Norgela

    (Uppsala Monitoring Centre (UMC))

  • Yaowares Oppamayun

    (Thai Food and Drug Administration, Health Product Vigilance Center)

  • D. K. Theo Raynor

    (University of Leeds)

  • Mehdi Bouhlel

    (Tunisian National Centre of Pharmacovigilance
    University of Monastir)

  • Federica Santoro

    (Uppsala Monitoring Centre (UMC))

  • Janet Sultana

    (Mater Dei Hospital)

Abstract

No abstract is available for this item.

Suggested Citation

  • Priya Bahri & Geoffrey Bowring & Brian D. Edwards & Christopher Anton & Jeffrey K. Aronson & Angela Caro-Rojas & Bruce P. J. Hugman & Peter G. Mol & Gianluca Trifirò & Katarina Ilic & Riadh Daghfous &, 2023. "Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance," Drug Safety, Springer, vol. 46(6), pages 517-532, June.
    • Handle: RePEc:spr:drugsa:v:46:y:2023:i:6:d:10.1007_s40264-023-01285-5
    DOI: 10.1007/s40264-023-01285-5
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-023-01285-5
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-023-01285-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Lisa M. Schwartz & Steven Woloshin & H. Gilbert Welch, 2007. "The Drug Facts Box: Providing Consumers with Simple Tabular Data on Drug Benefit and Harm," Medical Decision Making, , vol. 27(5), pages 655-662, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Pascal Aubertin & Thomas Frese & Jürgen Kasper & Wilfried Mau & Gabriele Meyer & Rafael Mikolajczyk & Matthias Richter & Jan Schildmann & Anke Steckelberg, 2023. "Efficacy of Three Numerical Presentation Formats on Lay People’s Comprehension and Risk Perception of Fact Boxes—A Randomized Controlled Pilot Study," IJERPH, MDPI, vol. 20(3), pages 1-16, January.
    2. Cox, Anthony D. & Cox, Dena, 2010. "A defense of direct-to-consumer prescription drug advertising," Business Horizons, Elsevier, vol. 53(2), pages 221-228, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:46:y:2023:i:6:d:10.1007_s40264-023-01285-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.